Alerts will be sent to your verified email
Verify Email
BROOKS
|
Brooks Laboratories
|
Medico Remedies
|
Lyka Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-23.88 % | 11.79 % | 145.3 % |
|
5yr average Equity Multiplier
|
1.78 | 2.18 | -0.06 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 1.48 | 0.64 |
|
5yr Avg Net Profit Margin
|
-23.79 % | 3.76 % | -21.64 % |
|
Price to Book
|
4.01 | 6.55 | 4.01 |
|
P/E
|
0.0 | 40.51 | 51.83 |
|
5yr Avg Cash Conversion Cycle
|
-10.34 Days | 34.15 Days | 16.94 Days |
|
Inventory Days
|
93.5 Days | 52.67 Days | 26.54 Days |
|
Days Receivable
|
66.75 Days | 107.96 Days | 77.33 Days |
|
Days Payable
|
179.8 Days | 136.18 Days | 133.6 Days |
|
5yr Average Interest Coverage Ratio
|
-11.84 | 9.64 | 0.6 |
|
5yr Avg ROCE
|
-15.03 % | 17.25 % | 22.35 % |
|
5yr Avg Operating Profit Margin
|
-13.23 % | 5.84 % | 20.24 % |
|
5 yr average Debt to Equity
|
0.21 | 0.3 | -0.79 |
|
5yr CAGR Net Profit
|
0.22 % | 38.44 % | -47.18 % |
|
5yr Average Return on Assets
|
-14.62 % | 5.66 % | -5.63 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.62 % | 63.79 % | 58.16 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-13.79 % | -9.55 % | 10.37 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
9.9 % | 0.0 | -0.72 % |
|
Brooks Laboratories
|
Medico Remedies
|
Lyka Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|